Dr. Sheth describes novel approaches for the prevention of recurrent intracerebral hemorrhage in brain hemorrhage survivors.
Recurrent intracerebral hemorrhage: new problem with an old target?
Dr. Sheth has received personal compensation for royalty, license fees, or contractual rights payments from
Alva Health. His institution (Yale) has received research support from Biogen, Novartis, Bard, Hyperfine.